Kalbe Farma (Indonesia) provided earnings guidance for the full year 2015. The company expected its full-year 2015 sales to grow 2%-3% year on year and its net profit to fall by 3%-4% year on year, amid slowing macroeconomic conditions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,445 IDR | 0.00% | +1.76% | -10.25% |
Apr. 30 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.25% | 4.18B | |
+33.11% | 709B | |
+30.77% | 595B | |
-1.84% | 367B | |
+20.23% | 334B | |
+5.71% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.21% | 171B |
- Stock Market
- Equities
- KLBF Stock
- News PT Kalbe Farma Tbk.
- Kalbe Farma Provides Earnings Guidance for the Full Year 2015